NCT07444099Enrolling by invitation
Early Postoperative Intervention in Gastric Cancer Patients
Early Postoperative Structured Intervention for Quality of Life and Prognosis in Gastric Cancer Patients After Neoadjuvant Therapy：: A Multicenter,Open Label Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 264 (estimated)
- First submitted
- 10 Feb 2026
- Start date
- 10 Feb 2026
- Primary completion date
- 10 Mar 2027
- Lead sponsor
- Qilu Hospital of Shandong University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07444099
What you commit to
- Study type: Interventional
- Planned participants: 264
- From 10 Feb 2026 to the primary completion date, 10 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing emergency surgery;
Other illness
- Patients with central nervous system diseases or psychiatric disorders;
- Patients with severe diseases of other organ systems;
- Patients with recurrent infectious diseases or severe comorbidities;
- Patients requiring synchronous surgery for other diseases;
Other
- Patients who developed any complication during hospitalization.
Who the study is looking for
- Age 18-80 years;
- Histologically confirmed adenocarcinoma by preoperative pathology;
- Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs);
- Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities;
- Signed informed consent and voluntary participation in this study;
- Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.